Basic Seniority Territory definition

Basic Seniority Territory means that Seniority District or Seniority Territory as defined in the Appendix B of this agreement.
Basic Seniority Territory as referred to in Clause 1, paragraph (e) and Clause 4, paragraph (c) of this Appendix "A" shall be those Job Security Eligibility territories as defined in Appendix "D" of this Agreement together with the rules written pursuant thereto.
Basic Seniority Territory means that Seniority Territory as defined in the Collective Agreement.

Examples of Basic Seniority Territory in a sentence

  • For the purpose of payment of benefits from the Job Security Fund, the existing Operating Department Superintendents' Divisions on CP Rail as of July 1, 1980 will be defined as constituting the Basic Seniority Territory for Road and Terminal Electricians and Helpers employed in the Operating Department on each Business Unit governed by the former Collective Agreement #34.

  • An employee may not delay an exercise of seniority under Rule beyond the calendar days specified in Rule unless there are no junior employees in their respective classification on the Basic Seniority Territory working and there are laid off junior employees in the classification on the Basic Seniority Territory.

  • During the year under review, stress and trauma healing workshops continued to be on demand.

  • Employees who do not elect above and have exhausted their seniority rights under their Basic Seniority Territory will have their name placed on their regional laid-off list.

  • Where these trades have been diminished to the extent that employees have nowhere on the Basic Seniority Territory to displace they shall be allowed to displace into one of the other designated trades in accordance with Appendix 45 and the natural flow chart defined therein.

  • A drug with minimal activity would be expected to have a BMRR of 10%.

  • It was not the intention of the parties to provide to employees at the location, Article 4.3, Option 1, 2, or 3 benefits, when there are junior employees holding permanent positions in the bargaining unit on the Basic Seniority Territory, who have not completed 8 or more years of CCS or commenced service on or after January 1, 1994, or have previously forfeited employment security benefits.

Related to Basic Seniority Territory

  • Coverage territory means the United States of America (including its territories and possessions), Puerto Rico and Canada.

  • U.S. Territory means American Samoa, the Commonwealth of the Northern Mariana Islands, Guam, the Commonwealth of Puerto Rico, or the U.S. Virgin Islands.

  • Service Territory means the geographic area within which PG&E as a Utility Distribution Company is authorized and required to provide electric transmission and distribution service.

  • Licensed Territory means worldwide.

  • Territory means worldwide.

  • Relevant Territory means Hong Kong or such other territory as the Directors may from time to time decide if the issued ordinary share capital of the Company is listed on a stock exchange in such territory;

  • Sales territory means an area of exclusive sales responsibility for the brand or brands of beer sold by a supplier as designated by an agreement.

  • customs territory means the territory of the country of each Contracting Party in which the Customs laws of that country are in force;

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Union territory means the territory of—

  • Licensed Product means a product or part of a product in the Licensed Field of Use: (A) the making, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent; or (B) which is made with, uses or incorporates any Technology.

  • Designated country end product means a WTO GPA country end product, a Free Trade Agreement country end product, a least developed country end product, or a Caribbean Basin country end product.

  • Nondesignated country end product means any end product that is not a U.S.-made end product or a designated country end product.

  • Exclusive Territory means (1) the states of Illinois, Wisconsin, and Indiana; and

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Clinical Trial means any human clinical trial of a Product.

  • Geographic Territory means the United States of America, including all of its territories and possessions, unless otherwise specified.

  • Covered Product The consumer product that You purchased concurrently with and is covered by this Agreement.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • WTO GPA country end product means an article that—

  • Licensed Compound means [***].

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Major Market Countries means the United States, Japan, England, Germany, France, Italy and Spain.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.